ArticleFrontiers in pharmacology2026

Structure-based virtual screening identifies ethyl rosmarinate as a SLC1A6-targeted therapeutic candidate for bladder cancer.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.